{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:03:51Z","timestamp":1780607031889,"version":"3.54.1"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Incremental hemodialysis (HD) can exploit the presence of renal urea clearance (KRU) to reduce the frequency and\/or dose of HD but must ensure adequate total weekly clearance, expressed as the so-called Continuous Equivalent Clearance (ECC). The aim of this study was to provide an app that could help the nephrologist prescribe dialysis parameters to achieve the appropriate ECC based on the patient's KRU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Recently, we designed a user-friendly tool for calculating dialysis dose in incremental HD which consists of a few rows of a common spreadsheet. We named it SPEEDY. It is able to provide results that are superimposable to those of Solute-Solver, the software recommended by the KDOQI clinical practice guidelines for HD adequacy. However, there were still difficulties with SPEEDY in calculating the dialysis dose to be prescribed in a timely manner. Therefore, we developed new formulas able to overcome this problem in the incremental HD setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>These new formulas have been utilized to build up the European Renal Calculator (EuReCa) app, freely available at https:\/\/clearance.streamlit.app. It is intended exclusively for nephrologists treating adult patients on maintenance HD. EuReCa app is made up of five modules with related instructions for users. It allows to choose and share with the patient the prescription of treatment frequency, dialysis dose, session length, dialyzer clearance, dialyzer device, blood flow rate, ultrafiltration rate, and protein intake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The EuReCa app provides guidance on prescribing key HD operating parameters. Therefore, it is particularly useful for prescribing and assessing incremental HD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/joneph\/aajaf028","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T17:57:33Z","timestamp":1773165453000},"page":"72-75","source":"Crossref","is-referenced-by-count":0,"title":["The European Renal Calculator (EuReCa) app: a user-friendly tool for calculating dialysis dose in incremental hemodialysis"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6297-5215","authenticated-orcid":false,"given":"Francesco Gaetano","family":"Casino","sequence":"first","affiliation":[{"name":"Associazione Nefrologica Gabriella Sebastio , Martina Franca ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Casino","sequence":"additional","affiliation":[{"name":"Cronos Europa , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-5471","authenticated-orcid":false,"given":"Carlo","family":"Basile","sequence":"additional","affiliation":[{"name":"Associazione Nefrologica Gabriella Sebastio , Martina Franca ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"2026060416371284800_aajaf028-B1","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2015.07.015","article-title":"KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update","volume":"66","author":"National Kidney Foundation","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2026060416371284800_aajaf028-B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/ndt\/17.suppl_7.24","article-title":"II.3 haemodialysis dose and residual renal function (Kr)","volume":"17","author":"European Best Practice Guidelines","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"2026060416371284800_aajaf028-B3","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1093\/oxfordjournals.ndt.a027616","article-title":"The equivalent renal urea clearance: a new parameter to assess dialysis dose","volume":"11","author":"Casino","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"2026060416371284800_aajaf028-B4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/ndt\/13.suppl_6.10","article-title":"The current place of urea kinetic modelling with respect to different dialysis modalities","volume":"13","author":"Gotch","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"2026060416371284800_aajaf028-B5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/ndt\/gfw339","article-title":"The variable target model: a paradigm shift in the incremental haemodialysis prescription","volume":"32","author":"Casino","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2026060416371284800_aajaf028-B6","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf147","article-title":"New formulas for calculating dialysis dose in incremental haemodialysis","author":"Casino","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026060416371284800_aajaf028-B7","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/ndt\/gfx343","article-title":"A user-friendly tool for incremental haemodialysis prescription","volume":"33","author":"Casino","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2026060416371284800_aajaf028-B8","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1053\/j.ajkd.2009.06.033","article-title":"Solute-solver: a web-based tool for modeling urea kinetics for a broad range of hemodialysis schedules in multiple patients","volume":"54","author":"Daugirdas","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2026060416371284800_aajaf028-B9","first-page":"3","article-title":"Could incremental haemodialysis be a new standard of care? A suggestion from a long-term observational study","volume":"39","author":"Casino","year":"2022","journal-title":"G Ital Nefrol"},{"key":"2026060416371284800_aajaf028-B10","author":"Casino"},{"key":"2026060416371284800_aajaf028-B11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.kint.2021.07.025","article-title":"A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function","volume":"101","author":"Vilar","year":"2022","journal-title":"Kidney Int"},{"key":"2026060416371284800_aajaf028-B12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/j.ajkd.2021.12.001","article-title":"Twice-weekly hemodialysis with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis: a pilot study","volume":"80","author":"Murea","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"2026060416371284800_aajaf028-B13","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2215\/CJN.0000000000000507","article-title":"Twice weekly versus thrice weekly hemodialysis-a pilot cross-over equivalence trial","volume":"19","author":"Lee","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026060416371284800_aajaf028-B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2025.09.048","article-title":"Randomized trial of twice-weekly vs. thrice-weekly hemodiafiltration for initiation of renal replacement therapy","author":"Lucas","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026060416371284800_aajaf028-B15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12882-018-1189-6","article-title":"IHDIP: a controlled randomized trial to assess the security and effectiveness of the incremental hemodialysis in incident patients","volume":"20","author":"Deira","year":"2019","journal-title":"BMC Nephrol"},{"key":"2026060416371284800_aajaf028-B16","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/ndt\/gfaa220","article-title":"The reasons for a clinical trial on incremental haemodialysis","volume":"35","author":"Casino","year":"2020","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/1\/72\/67287412\/aajaf028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/39\/1\/72\/67287412\/aajaf028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:37:20Z","timestamp":1780605440000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/39\/1\/72\/8512846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,10]]},"published-print":{"date-parts":[[2026,6,4]]}},"URL":"https:\/\/doi.org\/10.1093\/joneph\/aajaf028","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]}}}